Key facts
- This page summarizes John E. Kao's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 09 Aug 2022, 16:31.
John E. Kao - 05 Aug 2022 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- ALHC
- Reported as of
- 05 Aug 2022
- Net transaction value
- -$1,228,889
- SEC form
- 4
- Accepted by SEC
- 09 Aug 2022, 16:31:34 UTC
- Prior SEC filing
- 02 Aug 2022
- Next SEC filing
- 12 Aug 2022
- Source filing
- View source filing
- Reporting owner signature
- Richard A. Cross, as Attorney-in-Fact, for John E. Kao
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John E. Kao filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 09 Aug 2022.
Change
- Previous filing in this sequence was filed on 02 Aug 2022.
- Current net transaction value: -$1,228,889.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALHC
transaction
Common Stock
Sale
- Transaction value
- $1,152,779
- Shares
- -62,188
- Change %
- -1.8%
- Price
- $18.54
- Shares after
- 3,353,203
- Date
- 05 Aug 2022
- Ownership
- See Footnote
- Footnotes
- F1, F2, F3
ALHC
transaction
Common Stock
Sale
- Transaction value
- $76,110
- Shares
- -4,003
- Change %
- -0.12%
- Price
- $19.01
- Shares after
- 3,349,200
- Date
- 05 Aug 2022
- Ownership
- See Footnote
- Footnotes
- F1, F3, F4
ALHC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 781,353
- Date
- 05 Aug 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
Footnote F2
The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.00 to $18.99. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) and (4) to this Form 4.
Footnote F3
Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
Footnote F4
The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.00 to $19.14.